Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Regeneron Stock Is a Solid Long-Term Buy

By Dana Blankenhorn, InvestorPlace Contributor
Investors are excited about Regeneron stock for its Covid-19 treatment. They're missing the point. Regeneron is a great long-term buy.

Why Facebook Stock Will Reach $300 Sooner Than You Think

By Tezcan Gecgil, InvestorPlace Contributor
The tech giant's ad revenue is likely to increase in coming quarters, which will push Facebook stock to new highs.

The 3 Best Stocks for Beginning Investors

By Barbara Friedberg, InvestorPlace Contributor
Beginning investors can profit from stable blue chip firms with consistent dividends. Find out which stocks make the grade.

The Best Way to Play the Current Tech Rally Is eBay Stock

By Faizan Farooque, InvestorPlace Contributor
Covid-19 is bringing renewed interest in eBay stock, but the company's potential extends far beyond the current crisis. Here's why.

Co-Diagnostics Could Soar With Its Coronavirus Test

By Mark R. Hake, CFA
Co-Diagnostics may be worth much more than today's price. CODX stock could be worth two or three times more, under certain estimates.

Expect Canopy Growth Stock to Pass Its Big Earnings Test

By InvestorPlace Research Staff
Canopy Growth has rallied from March lows along with other cannabis stocks. As the sector shows signs of life, Canopy earnings need to be solid.

Aurora Stock Is a Contentious Contrarian Cannabis Play

By David Moadel, InvestorPlace Contributor
Brace yourself, because there will continue to be outsized daily price moves in Aurora stock. But there's potential for long-term gains.

7 Cheap Stocks to Buy With Great Potential

By Louis Navellier and the InvestorPlace Research Staff
In times of market turbulence, cheap stocks offer a unique way to escape the broad moves up and down and instead benefit from big potential.

It’s Not a Fantasy to Believe in DraftKings

By Chris Markoch, InvestorPlace Contributor
With live sporting events returning, even without fans, the games themselves represent a viable opportunity for DraftKings stock.

Virgin Galactic Stock Will Reach $30 Again, but the Timeline Is Cloudy

By David Moadel, InvestorPlace Contributor
Investors should expect a slow build in SPCE stock with an eye towards an eventual doubling of the share price.

Gaming Is a Billion-Dollar Opportunity for Amazon Stock

By Louis Navellier and the InvestorPlace Research Staff
Gaming is another example of how AMZN will continue to innovate and find new ways to break into new businesses to boost Amazon stock.

Intel Remains A Blue-Chip Stock to Buy Post-Pandemic

By Louis Navellier and the InvestorPlace Research Staff
Intel stock has held up remarkably well in 2020, as evidenced by first-quarter results, and move to the cloud means more upside ahead.

Here’s How to Make a Safer Wager on Penn National Gaming Stock

By Chris Tyler, InvestorPlace Contributor
Investors long PENN have been winning big, but today’s share price deserves a new strategy that plays a bit like craps using the options market

Facebook Stock to $1,000? It’s Possible Now Thanks to Shops

By Luke Lango, InvestorPlace Senior Investment Analyst
Newly announced Facebook Shops is a game-changer which cracks the ultra-valuable social commerce code, and could push FB stock to $1,000.

GE Stock Comeback Story is Delayed But Not Canceled

By Nicolas Chahine, InvestorPlace Contributor
GE stock come back story of 2020 will have to wait. But if management continues on its 2019 track it should make the turn eventually.

5 Top Stock Trades for Tuesday: BAC, SAVE, CCL, M, JPM

By Bret Kenwell, InvestorPlace Contributor
JPMorgan, Bank of America, Spirit Airlines, Macy's and Carnival Cruise are our top stock trades for Wednesday. So, let's look at the charts.

Inovio Stock Poised for Growth as Preliminary Research Shows Promise

By Louis Navellier and the InvestorPlace Research Staff
Vaccine trials are in progress, and although it isn't the only player on the field, Inovio stock has a clear head-start on the competition.

Earnings Show There’s No Reason to Let Nvidia Stock Go Yet

By InvestorPlace Research Staff
NVDA stock sits at the highs, and some investors might worry about valuation. But earnings highlight the long-term growth opportunity ahead.

Buy iBio Stock as an Effective Vaccine Could Be Imminent

By Louis Navellier and the InvestorPlace Research Staff
Seemingly everyone in the investing world is betting on a coronavirus vaccine. Here's why IBIO stock is a great way to play that trend.
Load More Articles